Clinical Trials Logo

Filter by:
NCT ID: NCT05067582 Active, not recruiting - Clinical trials for Autism Spectrum Disorder

A 12-Week Crossover Study to Assess the Efficacy, Safety and Tolerability of L1-79 in Subjects Aged 12-21 Years With Autism Spectrum Disorder

Start date: January 25, 2022
Phase: Phase 2
Study type: Interventional

This study will investigate the efficacy, safety and tolerability of L1-79 in participants aged 12-21 years who have been diagnosed with ASD with a score of >/= 70 on the Wechsler Abbreviated Scale of Intelligence (WASI-II), and a score of >/= 4 on the Clinical Global Impression of Severity of Illness (CGI-S) weighted for socialization.

NCT ID: NCT05067478 Active, not recruiting - Overactive Bladder Clinical Trials

Composur: Study to Understand the Performance of Vibegron in Participants With Overactive Bladder (OAB)

Start date: October 28, 2021
Phase:
Study type: Observational

This study will evaluate the treatment satisfaction, discontinuation, reasons for discontinuation, quality of life, healthcare resource utilization, and safety with Vibegron for the treatment of OAB in the context of real-world clinical practice.

NCT ID: NCT05067127 Active, not recruiting - C3 Glomerulopathy Clinical Trials

Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

VALIANT
Start date: November 12, 2021
Phase: Phase 3
Study type: Interventional

This is a Phase 3 study to assess the efficacy and safety of twice-weekly subcutaneous (SC) doses of pegcetacoplan compared to placebo in patients with C3 glomerulopathy (C3G) or immune-complex membranoproliferative glomerulonephritis (IC-MPGN) on the basis of a reduction in proteinuria.

NCT ID: NCT05066997 Active, not recruiting - Clinical trials for Diabetic Macular Edema

Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects With Diabetic Macular Edema

Start date: October 19, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of OCS-01 ophthalmic suspension versus vehicle alone in subjects with DME

NCT ID: NCT05066542 Active, not recruiting - Type 2 Diabetes Clinical Trials

Recreational Basketball to Increase Participation in Diabetes Prevention

DPPHoops
Start date: June 11, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the efficacy of adapting the National Diabetes Prevention Program (NDPP) to include recreational sports in effort to increase physical activity (PA) and promote lifestyle changes that can help reduce the risk of developing Type 2 Diabetes Mellitus. The hypothesis is that both the traditional NDPP and the NDPP+ Basketball will be considered feasible. The primary outcome is to assess whether the intervention (NDPP+BB) compared to the standard of care (NDPP only) will result in greater weight loss, lower A1c, and increased engagement in physical activity.

NCT ID: NCT05065944 Active, not recruiting - Prostate Cancer Clinical Trials

Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer Center

Start date: November 16, 2021
Phase:
Study type: Observational

This is a randomized controlled trial of patients scheduled for hysterectomy or prostatectomy surgeries who undergo a pre-anesthesia evaluation at Moffitt Cancer Center PreAnesthesia Testing (PAT) clinic. Traditionally, patients who met certain criteria based on type of surgery or comorbidities would undergo an in-person evaluation in our clinic. In order to make our patient's care more convenient and accessible, investigators have introduced telemedicine evaluation for a certain subset of patients meeting specific criteria. Investigators aim with this randomized trial to investigate the hypothesis that telemedicine pre-anesthesia evaluation is non-inferior to in-person evaluation from the standpoint of day of surgery cancellation rate.

NCT ID: NCT05065866 Active, not recruiting - Hodgkin Lymphoma Clinical Trials

Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy

Start date: November 18, 2021
Phase: Phase 1
Study type: Interventional

The purpose of the study is to find a safe dose and to evaluate the safety and tolerability of the drug BMS-986345, in combination with duvelisib.

NCT ID: NCT05065008 Active, not recruiting - Healthy Clinical Trials

The Roles of Gut Microbiome in UTI Susceptible Women

Start date: October 18, 2021
Phase: N/A
Study type: Interventional

Clinical trials on cranberry juice and UTI prevention yielded both positive and negative results for unknown reason. Gut microbiome in women affect the absorption and metabolism of cranberry bioactives. The variation of gut microbiome is a probable mechanism for metabolic polymorphisms and disparity in UTI prevention in women.

NCT ID: NCT05064722 Active, not recruiting - Obesity, Morbid Clinical Trials

Duodenal-Ileal Diversion in Obese Patients Undergoing Primary Sleeve or Those With Inadequate Weight Loss After Sleeve

Start date: November 8, 2021
Phase: N/A
Study type: Interventional

The objectives of this study are to assess the initial safety and device functionality of the SFM Anastomosis System including delivery systems when used to create a dual-path duodenal-ileal (D-I) diversion either during sleeve gastrectomy (i.e., SNAP-S procedure) or patients with prior sleeve gastrectomy who experience inadequate weight loss (i.e., SNAP-PS procedure). Additionally, the study is designed to evaluate the potential of the SNAP-S/SNAP-PS procedures to induce weight loss and to improve metabolic comorbidities in obese subjects.

NCT ID: NCT05064410 Active, not recruiting - Colorectal Cancer Clinical Trials

Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative

Start date: May 11, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to provide educational materials and information regarding colorectal cancer (CRC), CRC screenings, and United States Preventive Services Task Force's (USPSTF) screening recommendations. USPSTF recommends screening for colorectal cancer starting at age 45 years and continuing until age 75 years.